SoluLinK, Inc. is a biotech company that provides linking reagents, conjugation kits, and conjugation services for life science research, diagnostics, and pharmaceutical markets. The company offers a wide range of products including biotin and digoxigenin labeling, magnetic beads and agarose, biotin and streptavidin, antibody labeling, peptide linking and synthesis, and crosslinking products.
Founded in 2000 and headquartered in San Diego, California, SoluLinK, Inc. has a global presence, distributing its products through various partners in countries such as Australia, Austria, Belgium, Canada, China, the Czech Republic, Denmark, Finland, France, Germany, India, Ireland, Israel, Italy, Japan, South Korea, the Netherlands, Portugal, the Russian Federation, Singapore, Spain, Sweden, Switzerland, Taiwan, the United Kingdom, and the United States.
The company's last investment amounted to $430.00K, in the form of debt financing, on 02 December 2013.
SoluLinK, Inc. operates in the Biotechnology and Health Care industries, positioning itself as a key player in providing precision linking solutions for diagnostics and pharmaceuticals.
